Effect of age and gender on tirilazad pharmacokinetics in humans

Clinical Pharmacology & Therapeutics

Volumn 55, Issue 4, 1994, Pages 378-384

  Hulst, Laura K ^a,b   Fleishaker, Joseph C ^a,b   Peters, Gary R ^a,b   Harry, John D ^a,b   Wright, D Mark ^a,b   Ward, Penelope ^a,b  

^a PFIZER INC   (United States)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TIRILAZAD;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG STRUCTURE; ELECTROCARDIOGRAM; FEMALE; GENDER; HEART RATE; HEART RHYTHM; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; COMPARATIVE STUDY; FEMALE; HALF-LIFE; HUMAN; INFUSIONS, INTRAVENOUS; LIPID PEROXIDES; MALE; PREGNATRIENES; REGRESSION ANALYSIS; SEX CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T;

EID: 0028356191     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1994.45     Document Type: Article

References (0)